Your cart is currently empty!
Tesamorelin
Price range: $60.00 through $700.00
What is Tesamorelin? Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH), studied for its ability to stimulate endogenous growth hormone production. Initially developed and approved for the reduction of visceral adipose tissue in specific clinical populations, it is now being investigated in preclinical and clinical research settings for its potential effects on fat metabolism, muscle physiology, cognitive processes, and metabolic regulation. Studies continue to explore its impact on lipid profiles, insulin sensitivity, and overall endocrine function. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.
Description
| Chemical Formula | C221H366N72O67S |
| Molecular Mass | ~5135.9 Da |
| CAS Number | 218949-48-5 |
| Form | Lyophilized peptide powder |
| Shelf Life | 24 months (lyophilized) |
| Intended Use | For preclinical and in vitro research only |
| Storage | −20 °C (dry powder), −80 °C (after reconstitution) |
In experimental research settings, tesamorelin is used as a stabilized growth hormone–releasing hormone (GHRH) analog to investigate upstream regulation of the GH/IGF signaling axis. Its use in controlled models supports studies of receptor-mediated signaling, downstream second-messenger responses, and transcriptional changes associated with GHRH pathway activation.
Preclinical investigations commonly employ tesamorelin as a tool compound for evaluating signaling kinetics, receptor selectivity, and pathway cross-talk in endocrine and metabolic research frameworks. Experimental outcomes can vary depending on model system, exposure duration, and assay design.
Intended for laboratory research use only. Not for human or animal consumption, medical diagnosis, or therapeutic application.
Additional information
| Volume | 10MG, KIT (10 x 10MG) |
|---|
Description
| Chemical Formula | C221H366N72O67S |
| Molecular Mass | ~5135.9 Da |
| CAS Number | 218949-48-5 |
| Form | Lyophilized peptide powder |
| Shelf Life | 24 months (lyophilized) |
| Intended Use | For preclinical and in vitro research only |
| Storage | −20 °C (dry powder), −80 °C (after reconstitution) |
In experimental research settings, tesamorelin is used as a stabilized growth hormone–releasing hormone (GHRH) analog to investigate upstream regulation of the GH/IGF signaling axis. Its use in controlled models supports studies of receptor-mediated signaling, downstream second-messenger responses, and transcriptional changes associated with GHRH pathway activation.
Preclinical investigations commonly employ tesamorelin as a tool compound for evaluating signaling kinetics, receptor selectivity, and pathway cross-talk in endocrine and metabolic research frameworks. Experimental outcomes can vary depending on model system, exposure duration, and assay design.
Intended for laboratory research use only. Not for human or animal consumption, medical diagnosis, or therapeutic application.
Additional information
| Volume | 10MG, KIT (10 x 10MG) |
|---|
Reviews
There are no reviews yet.
Related products
-
CJC-1295/Ipamorelin
Price range: $52.00 through $520.00 -
IGF1-LR3
Price range: $70.00 through $600.00 -
Sermorelin
$30.00
Reviews
There are no reviews yet.